SBC Medical Group Holdings Inc

On March 27, 2025, the Company’s Board of Directors approved certain executive officer updates, including the replacement of Ryoji Murata, the Company’s current Chief Financial Officer (principal financial officer), effective April 1, 2025. Yuya Yoshida, 46, the Company’s current Chief Operating Officer will continue in that role and also serve as Chief Financial Officer (principal financial officer), effective April 1, 2025. Mr. Murata will continue to serve as the Company’s principal accounting officer.

Mr. Yoshida has served as our Chief Operating Officer and member of our Board of Directors since September 17, 2024, and in the same positions, since September 29, 2023, with SBC Medical Group, Inc. (the legacy business that because the Company’s business). Mr. Yoshida has also served as the Executive Vice President and the Chief Financial Officer of SBC Medical Group Co., Ltd. (Japan) since July 1, 2023. From January 2016 to June 2023, Mr. Yoshida worked in Corporate Development (Global Head and Director of Corporate Development in 2018) at Rakuten Group Co., Ltd. From 2003 to 2016, Mr. Yoshida worked in securities, principal M&A, and investment banking at Mitsubishi UFJ Financial Group. Mr. Yoshida has extensive knowledge in E-Commerce, logistics, settlement, finance, mergers and acquisitions and divestiture transactions. Mr. Yoshida graduated with a Master of Law degree from Keio University in 2003. Mr. Yoshida also graduated with a Master of Business Administration degree from UCLA Anderson Business School in 2014.

Mr. Yoshida was not appointed pursuant to any arrangement or understanding with any other person, has no family relationships with any director or executive officer of the Company, and other than his previously reported employment arrangement with the Company, and other than his previously reported employment arrangement with the Company, and there are no transactions involving Mr. Yoshida that would be required to be reported under Item 404(a) of Regulation S-K.